Search Results 131-140 of 16933 for monoclonal antibody
Monoclonal antibodies, such ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4 monoclonal antibody).
... monoclonal antibody. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
The purpose of this study is to assess the effects of DCSZ11, an anti-CD93 monoclonal antibody, as a monotherapy in patients with advanced or metastatic solid ...
Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...
The treatments include IMiDs, proteosome inhibitors, chemotherapy, monoclonal antibodies and stem cell transplantation.To c. Participation eligibility.
... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. Melphalan flufenamide belongs to the group of medicines ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ... History of severe hypersensitivity reaction to any monoclonal antibody.
Mayo Clinic was a worldwide leader in using monoclonal antibody therapy. This therapy significantly reduced the hospitalization rate and decreased mortality of ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.